Abstract
Sham-operated rats underwent a similar flank incision. The followed by the addition of 4 ml of 0.5 M NaOH for a further 2 h period. Samples from the supernatant were right kidney was perfused ex vivo and renal function measured 21 days after surgery. All procedures were undertaken counted for 3H. according to the regulations laid down by HM Government (Animals Scientific Procedures Act, UK 1986).
Materials
Genistein was from Calibiochem, mouse anti-human IGF-I
Isolated perfused rat kidney (IPRK)
antibody from Upstate Biotechnology, TCS Biochemicals, UK, and recombinant human IGF-I from Kabi, Sweden. All Rats were anaesthetized with 125 mg/kg thiopentone, and other materials including mouse IgG 1k were obtained from the kidney was removed by a non-ischaemic technique [8] .
Sigma. Following an intravenous injection of heparin (1000 U/kg), the right ureter was cannulated and the right adrenal artery ligated. The right renal artery was cannulated via the superior Statistical analysis mesenteric artery, perfusion was started in situ and the right kidney was transferred to a recirculating perfusion system. Results were expressed as mean±SEM. Students t-test and The perfusate consisted of a modified Krebs-Henseleit solu-linear regression analysis were performed using Excel 5.1 tion containing 3.5% polygeline gassed with 95% O 2 /5% CO 2 software. and maintained at 37°C. Perfusion pressure was measured from a point inside the renal artery and was maintained at 100 mmHg by a servo-controlled pump. Renal perfusate flow (RPF ) was monitored continuously from the speed of the Results servo-pump.
Hyperfiltration and hyperperfusion in the IPRK

Experimental protocol
The were dissolved in phosphate-buffered than from sham-operated animals (0.39±0.05 ml/min, saline and 50 mg [9] was infused into the perfusion circuit n=8). This represented an increase of 92%. The renal over a 10 min period using a syringe pump (50 mg/ml, perfusate flow was also significantly higher (P<0.05) 100 ml/min). Delivery syringes and tubing were primed with in kidneys obtained from UNx rats (28.2±2.7 ml/min, 1% bovine serum albumin to avoid antibody adherence. For n=8) than from sham-operated animals (22.5±0.8 studies with the IGF-I antibody, samples were collected for ml/min, n=8). This represented an increase of 29%, a a 60 min period following its addition to the perfusate. similar change to the increase in kidney growth.
Antibody neutralization
Two days prior to assay, opossum kidney (OK ) cells were seeded in Dulbecco's modified Eagle's medium (DMEM ) containing -glutamine, 5% fetal calf serum (FCS), 100 IU/ml penicillin and 100 mg/ml streptomycin. All cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 in air. Cells were plated in 75 cm2 tissue culture flasks. One day prior to assay, cells were serum starved. On the day of the assay, the culture medium was replaced by medium which had been pre-incubated for 1 h with either recombinant human IGF-I (15 ng/ml ) alone or together with an increasing concentration of IGF-I antibody (0-80 mg/ml ). Cells were incubated for 24 h.
Following this incubation, the culture medium was removed and cells were pulsed with medium containing Fig. 1. [14C ]Inulin clearance, renal perfusate flow and the dry weight 2 mCi/ml [3H ]thymidine and 0.5% FCS for 4 h. Cells were of kidneys perfused ex vivo at constant pressure (100 mmHg) washed three times with 4 mM thymidine and incubated with obtained from either sham-operated (unhatched) or UNx (hatched ) rats, 21 days after surgery. n=8 per group. 10 ml of ice-cold, 5% trichloroacetic acid (TCA) for 90 min Antibody neutralization is shown in Figure 3 as the difference in mean [14C ]inulin clearance between kidneys obtained from The ability of the IGF-I antibody to neutralize a UNx and sham-operated animals (n=4 per group). biological response to exogenous recombinant IGF-I One hour after the addition of IGF-I antibody to the (rhIGF-I ) in a kidney cell line is shown in Figure 2 . renal perfusate, renal hyperfiltration had decreased RhIGF-I (15 ng/ml ) produced a 100% increase in the with time (R=0.8939, P<0.01) to 47% of its original incorporation of radiolabelled thymidine into DNA, value without reaching a new stable baseline. Perfusion an effect entirely prevented by the IGF-I antibody at of kidneys obtained from UNx rats with 50 mg of 60 mg/ml. (Figure 4) . Genistein administration did not produce suggested the involvement of intrarenal mechanisms rather than a systemic response. Table 1 . Prior to antibody administration, [13] , and the presence of IGF-I protein in the glomerrenal perfusate flow was significantly higher in kidneys ulus has been detected recently by immunohistochemobtained from UNx rats than sham-operated animals istry [14], the mesangial cell being the major site of (P<0.05). This difference remained throughout the production [15] . An increase in vascular load, such as period of kidney perfusion, the renal perfusate flow might be expected following UNx, also increases the increasing with time in kidneys obtained from both expression of IGF-I in blood vessels [16 ] . The use of sham-operated and UNx rats. Renal hyperperfusion is the IPRK to study mechanisms associated with renal shown in Figure 3 as the difference in mean renal hyperfiltration avoided both the measurement of perfusate flow between kidneys obtained from UNx apparent hyperfiltration due to an increased blood and sham-operated animals (n=4 per group). Despite volume [17] and changes in renal function being generthe reduction in hyperfiltration, renal hyperperfusion ated indirectly from the systemic effects of drug inhibremained unaffected by IGF-I antibody administra-itors or antibodies. Changes in IGF-I biochemistry tion. Perfusion of kidneys obtained from UNx rats following UNx previously have been associated with with 50 mg of mouse IgG 1k produced no change in the development of compensatory growth rather than renal perfusate flow (25.9±3.2 to 28.1±3.3 ml/min, hyperfiltration [1, 2] . However, the involvement of n=4).
IGF-I in the present study could not be attributed to The effect of genistein on renal perfusate flow is also kidney growth since IGF-I inhibitors were adminisshown in Table 1 . Prior to genistein administration, tered to the kidney within the perfusion system, ex vivo. renal perfusate flow was significantly higher in kidneys
In the present IPRK study, renal hyperfiltration was obtained from UNx rats than sham-operated animals reduced by a neutralizing IGF-I antibody and abol-(P<0.05). This difference remained throughout the ished by genistein, suggesting a mediator role for period of perfusion, the renal perfusate flow increasing IGF-I. As expected, the effect of the IGF-I antibody with time in kidneys obtained from both sham-was relatively slow, with hyperfiltration still declining operated and UNx rats. The effect of genistein on after a 60 min perfusion period in the absence of renal hyperperfusion is shown in Figure 4 . In contrast changes in renal hyperperfusion. Hyperfiltration was to the abolition of hyperfiltration, hyperperfusion abolished after a 30 min perfusion period with showed a modest but significant (R=0.8938, P<0.01) genistein, a non-selective inhibitor of tyrosine kinase decline with time of~30%.
[10]. Tyrosine kinase is an enzyme involved in the early stages of signal transduction following activation
Discussion
of the IGF type I receptor [11] . Neither the neutralizing antibody nor genistein reduced the GFR or RPF in kidneys obtained from sham-operated animals. The The detection of renal hyperfiltration and hyperpermodest inhibition of hyperperfusion induced by fusion following UNx in kidneys perfused ex vivo genistein but not by the IGF-I antibody may be explained either by the involvement of tyrosine kinase in the control of vascular smooth muscle contractility [18] or by other pharmacological properties of genistein. The mechanism of renal hyperperfusion would therefore appear to be independent of hyperfiltration, and within our IPRK system has yet to be separated from kidney growth. The IGF-I antibody employed was a monoclonal anti-human IGF-I (class IgG 1k ) raised in the mouse [9] . Control studies using a mouse immunoglobulin (IgG 1k ) showed no effect on GFR in perfused kidneys from UNx rats. The ability of the antibody to neutralize the biological response to IGF-I was examined in OK cells where the increase in thymidine incorporation induced by recombinant human IGF-I was completely Fig. 4 . Effect of genistein (6.5 mM ) on renal hyperfiltration and neutralized, consistent with previous studies in rat hyperperfusion following 21 day unilateral nephrectomy. Renal osteoblasts [19] . In the IPRK, at 50 mg, the IGF-I hyperfiltration ($) or renal hyperperfusion (#) were calculated as antibody dose was considered to be in excess of that the difference between the mean [14C ]inulin clearance or the mean required to neutralize the effect endogenous IGF-I renal perfusate flow, respectively, measured in groups of kidneys (n=4 per group) obtained from either UNx or sham-operated rats. generated in the renal glomerulus. In a perfusion
